If this hypothesis is correct, treatment with insulin in women with obesity-T2D might not only correct elevated blood glucose levels (poorly controlled in this group) but could also correct hepcidin levels and lower iron stores, which are linked to alleviated insulin resistance14. The gene discussed is HAMP; the disease is type 2 diabetes mellitus.